MindMed
summary primary mechanism less specific low affinity sigma antagonist more specific low affinity for alpha beta nicotinic receptors reinforcement decreased morphine self administration decreased morphine self administration natural reinforcers withdrawal severity decreased responding for water mor decreases likely driven by activity bradycardia hallucinations tremors none on none noted in locus adverse effects | MindMed
Company
Deck Type
Deck date
May 2022
Slide
23 of 40
Other recent decks by MindMed
Investor Presentation
January 2025
Investor Presentation
December 2024
Investor Presentation
November 2024
Results
November 2023
Search Thousands of Presentations by World Leading Companies

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases
© 2021-2024 Slidebook.io